DIKUL - logo
E-viri
Recenzirano Odprti dostop
  • Management of Acute and Rec...
    Chiabrando, Juan Guido; Bonaventura, Aldo; Vecchié, Alessandra; Wohlford, George F; Mauro, Adolfo G; Jordan, Jennifer H; Grizzard, John D; Montecucco, Fabrizio; Berrocal, Daniel Horacio; Brucato, Antonio; Imazio, Massimo; Abbate, Antonio

    Journal of the American College of Cardiology, 2020-Jan-07, 20200107, Letnik: 75, Številka: 1
    Journal Article

    Pericarditis refers to the inflammation of the pericardial layers, resulting from a variety of stimuli triggering a stereotyped immune response, and characterized by chest pain associated often with peculiar electrocardiographic changes and, at times, accompanied by pericardial effusion. Acute pericarditis is generally self-limited and not life-threatening; yet, it may cause significant short-term disability, be complicated by either a large pericardial effusion or tamponade, and carry a significant risk of recurrence. The mainstay of treatment of pericarditis is represented by anti-inflammatory drugs. Anti-inflammatory treatments vary, however, in both effectiveness and side-effect profile. The objective of this review is to summarize the up-to-date management of acute and recurrent pericarditis.